FDA Approved: BINOSTO — Supplemental Application (Radius Health, Inc.)

View source ↗

Summary

FDA approves a supplemental application for BINOSTO (alendronate sodium) submitted by Radius Health, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucocorticoid-induced Osteoporosis
• Osteoporosis in Men
• Paget Disease of Bone
• Postmenopausal Osteoporosis

Drugs mentioned

• BINOSTO (ALENDRONATE SODIUM)

Snippet

SUPPL AP for BINOSTO (ALENDRONATE SODIUM)